This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12http://dx.doi.org/10.20452/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q92615587
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xineru de 2020 наукова стаття, опублікована 14 січня 2020 scientific article published on 14 January 2020 wetenschappelijk artikel article scientifique publié en 2020
p:P577
wds:Q92615587-21EBC686-5036-4E90-B061-D57AD03D1B21
wdt:P577
2020-01-14T00:00:00Z
p:P2093
wds:Q92615587-D1A7955D-2ABF-4F61-92A8-72BE22766ABE wds:Q92615587-DBD34F5D-00CE-489D-8B0D-2B17A95F677F wds:Q92615587-1DF1FB41-ADA4-4DC2-B1A4-D7B8CE34D396
wdt:P2093
Anna Gruca Monika Ziemianin Wojciech Dyga
rdfs:label
Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency
skos:prefLabel
Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency
schema:name
Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency
p:P50
wds:Q92615587-DE825617-01C4-4E21-966C-443792320822 wds:Q92615587-226674F4-9D88-4CA4-9391-FAC7361805D5 wds:Q92615587-324565EA-51EE-40BF-8595-FEC9E53C0E27 wds:Q92615587-BB38F9E9-6FDC-427B-B878-14ED895CC433 wds:Q92615587-BC67ACDD-AFEF-4C24-96D2-584D4F199840 wds:Q92615587-EBE21CFD-7649-49EC-9C52-12AA61C0B9F5 wds:Q92615587-EECF3420-E0BC-4B43-9DA4-F369E865FDCE
wdt:P50
wd:Q59633430 wd:Q97285375 wd:Q61090238 wd:Q124607522 wd:Q59634043 wd:Q118277342 wd:Q112132172
p:P1476
wds:Q92615587-5C79EF27-6692-4FCE-8F87-7A1CB1E88DEB
wdt:P1476
Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency
p:P304
wds:Q92615587-608A0846-6825-443C-AE0B-724D63EC59BA
wdt:P304
79-88
p:P31
wds:Q92615587-71FEFF11-44FC-42FA-8533-B2FE6CB0AA12
wdt:P31
wd:Q13442814
p:P921
wds:Q92615587-0DA2CB19-BDF3-40F0-9D12-92667DCAF6A5 wds:Q92615587-57E6806B-D4CA-44DF-AA1E-695850B6DA4C
wdt:P921
wd:Q2096745 wd:Q18553584
p:P698
wds:Q92615587-4D3E7F79-2202-42B3-A71D-E5049C0EE73C
wdtn:P698
n8:31933486
wdt:P698
31933486
p:P1433
wds:Q92615587-A7170018-D6C4-4647-982F-CBCA600B2A39
wdt:P1433
wd:Q26853874
p:P433
wds:Q92615587-8E04C201-243E-4C31-AAB5-E8807A1AD689
p:P478
wds:Q92615587-E41D1840-2B3B-427F-AB08-C285E2BEF640
wdt:P433
2
wdt:P478
130
p:P356
wds:Q92615587-1D4C98DE-3F04-48FC-9CA2-956B839C820D
wdtn:P356
n12:PAMW.15138
wdt:P356
10.20452/PAMW.15138